OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
-1.12%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$64.2M
AUM Growth
+$64.2M
Cap. Flow
-$3.24M
Cap. Flow %
-5.04%
Top 10 Hldgs %
94.89%
Holding
15
New
–
Increased
–
Reduced
4
Closed
–

Top Buys

No buys this quarter

Top Sells

1
EVLV icon
Evolv Technologies
EVLV
$1.97M
2
IONQ icon
IonQ
IONQ
$1.01M
3
LABP
Landos Biopharma, Inc. Common Stock
LABP
$244K
4
CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
$9.6K

Sector Composition

1 Healthcare 88.55%
2 Technology 9.3%
3 Industrials 2.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
$11.8M 18.39%
2,937,615
– –
PMVP icon
2
PMV Pharmaceuticals
PMVP
$74.2M
$11.8M 18.33%
989,232
– –
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$10.9M 16.95%
536,693
– –
JBIO
4
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$10M 15.59%
603,762
– –
IONQ icon
5
IonQ
IONQ
$12.7B
$5.97M 9.3%
1,177,597
-200,000
-15% -$1.01M
CYT
6
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$4.74M 7.38%
2,469,572
-5,000
-0.2% -$9.6K
VOR icon
7
Vor Biopharma
VOR
$250M
$1.49M 2.32%
374,714
– –
DTIL icon
8
Precision BioSciences
DTIL
$57.8M
$1.46M 2.28%
1,123,913
– –
RNAC icon
9
Cartesian Therapeutics
RNAC
$261M
$1.42M 2.2%
862,543
– –
EVLV icon
10
Evolv Technologies
EVLV
$1.42B
$1.38M 2.15%
652,475
-930,246
-59% -$1.97M
LENZ
11
LENZ Therapeutics
LENZ
$1.1B
$1.29M 2.01%
406,308
– –
LABP
12
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$804K 1.25%
1,237,667
-375,097
-23% -$244K
EFTR
13
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$587K 0.91%
1,025,697
– –
SPRO icon
14
Spero Therapeutics
SPRO
$116M
$498K 0.78%
249,070
– –
QTTB icon
15
Q32 Bio
QTTB
$20.9M
$103K 0.16%
64,000
– –